These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
544 related articles for article (PubMed ID: 11431713)
1. Morphologic typing of papillary renal cell carcinoma: comparison of growth kinetics and patient survival in 66 cases. Delahunt B; Eble JN; McCredie MR; Bethwaite PB; Stewart JH; Bilous AM Hum Pathol; 2001 Jun; 32(6):590-5. PubMed ID: 11431713 [TBL] [Abstract][Full Text] [Related]
2. Nucleolar grade but not Fuhrman grade is applicable to papillary renal cell carcinoma. Sika-Paotonu D; Bethwaite PB; McCredie MR; William Jordan T; Delahunt B Am J Surg Pathol; 2006 Sep; 30(9):1091-6. PubMed ID: 16931953 [TBL] [Abstract][Full Text] [Related]
3. [Papillary renal cell carcinoma: clinico-pathologic studies of 33 cases]. Liu LN; Chen GY; Wang P; Zhang CH; Huang SF Zhonghua Zhong Liu Za Zhi; 2005 Feb; 27(2):102-5. PubMed ID: 15946550 [TBL] [Abstract][Full Text] [Related]
4. Papillary renal cell carcinoma with oncocytic cells and nonoverlapping low grade nuclei: expanding the morphologic spectrum with emphasis on clinicopathologic, immunohistochemical and molecular features. Kunju LP; Wojno K; Wolf JS; Cheng L; Shah RB Hum Pathol; 2008 Jan; 39(1):96-101. PubMed ID: 17949780 [TBL] [Abstract][Full Text] [Related]
5. Morphological subtyping of papillary renal cell carcinoma: clinicopathological characteristics and prognosis. Yamashita S; Ioritani N; Oikawa K; Aizawa M; Endoh M; Arai Y Int J Urol; 2007 Aug; 14(8):679-83. PubMed ID: 17681054 [TBL] [Abstract][Full Text] [Related]
6. Clinicopathologic and molecular correlations of necrosis in the primary tumor of patients with renal cell carcinoma. Lam JS; Shvarts O; Said JW; Pantuck AJ; Seligson DB; Aldridge ME; Bui MH; Liu X; Horvath S; Figlin RA; Belldegrun AS Cancer; 2005 Jun; 103(12):2517-25. PubMed ID: 15880379 [TBL] [Abstract][Full Text] [Related]
7. Morphologic subtyping of papillary renal cell carcinoma: correlation with prognosis and differential expression of MUC1 between the two subtypes. Leroy X; Zini L; Leteurtre E; Zerimech F; Porchet N; Aubert JP; Gosselin B; Copin MC Mod Pathol; 2002 Nov; 15(11):1126-30. PubMed ID: 12429790 [TBL] [Abstract][Full Text] [Related]
8. Survival analysis of 130 patients with papillary renal cell carcinoma: prognostic utility of type 1 and type 2 subclassification. Pignot G; Elie C; Conquy S; Vieillefond A; Flam T; Zerbib M; Debré B; Amsellem-Ouazana D Urology; 2007 Feb; 69(2):230-5. PubMed ID: 17275070 [TBL] [Abstract][Full Text] [Related]
9. Epidermal growth factor receptor and transforming growth factor alpha expression in papillary and nonpapillary renal cell carcinoma: correlation with metastatic behavior and prognosis. Uhlman DL; Nguyen P; Manivel JC; Zhang G; Hagen K; Fraley E; Aeppli D; Niehans GA Clin Cancer Res; 1995 Aug; 1(8):913-20. PubMed ID: 9816062 [TBL] [Abstract][Full Text] [Related]
10. Papillary renal cell carcinoma: a clinicopathologic and immunohistochemical study of 105 tumors. Delahunt B; Eble JN Mod Pathol; 1997 Jun; 10(6):537-44. PubMed ID: 9195569 [TBL] [Abstract][Full Text] [Related]
12. Long-term survival of patients with unilateral sporadic multifocal renal cell carcinoma according to histologic subtype compared with patients with solitary tumors after radical nephrectomy. Dimarco DS; Lohse CM; Zincke H; Cheville JC; Blute ML Urology; 2004 Sep; 64(3):462-7. PubMed ID: 15351571 [TBL] [Abstract][Full Text] [Related]
13. Cytogenetic and morphologic typing of 58 papillary renal cell carcinomas: evidence for a cytogenetic evolution of type 2 from type 1 tumors. Gunawan B; von Heydebreck A; Fritsch T; Huber W; Ringert RH; Jakse G; Füzesi L Cancer Res; 2003 Oct; 63(19):6200-5. PubMed ID: 14559804 [TBL] [Abstract][Full Text] [Related]
14. Clear cell tubulopapillary renal cell carcinoma: a study of 36 distinctive low-grade epithelial tumors of the kidney. Aydin H; Chen L; Cheng L; Vaziri S; He H; Ganapathi R; Delahunt B; Magi-Galluzzi C; Zhou M Am J Surg Pathol; 2010 Nov; 34(11):1608-21. PubMed ID: 20924276 [TBL] [Abstract][Full Text] [Related]
15. Minichromosome maintenance protein 2 expression in normal kidney and renal cell carcinomas: relationship to tumor dormancy and potential clinical utility. Rodins K; Cheale M; Coleman N; Fox SB Clin Cancer Res; 2002 Apr; 8(4):1075-81. PubMed ID: 11948116 [TBL] [Abstract][Full Text] [Related]
16. Histological subtyping and nuclear grading of renal cell carcinoma and their implications for survival: a retrospective nation-wide study of 629 patients. Gudbjartsson T; Hardarson S; Petursdottir V; Thoroddsen A; Magnusson J; Einarsson GV Eur Urol; 2005 Oct; 48(4):593-600. PubMed ID: 15964127 [TBL] [Abstract][Full Text] [Related]
17. Prognostic utility of the recently recommended histologic classification and revised TNM staging system of renal cell carcinoma: a Swiss experience with 588 tumors. Moch H; Gasser T; Amin MB; Torhorst J; Sauter G; Mihatsch MJ Cancer; 2000 Aug; 89(3):604-14. PubMed ID: 10931460 [TBL] [Abstract][Full Text] [Related]
18. Renal tubulocystic carcinoma is closely related to papillary renal cell carcinoma: implications for pathologic classification. Zhou M; Yang XJ; Lopez JI; Shah RB; Hes O; Shen SS; Li R; Yang Y; Lin F; Elson P; Sercia L; Magi-Galluzzi C; Tubbs R Am J Surg Pathol; 2009 Dec; 33(12):1840-9. PubMed ID: 19898225 [TBL] [Abstract][Full Text] [Related]
19. A novel tumor grading scheme for chromophobe renal cell carcinoma: prognostic utility and comparison with Fuhrman nuclear grade. Paner GP; Amin MB; Alvarado-Cabrero I; Young AN; Stricker HJ; Moch H; Lyles RH Am J Surg Pathol; 2010 Sep; 34(9):1233-40. PubMed ID: 20679882 [TBL] [Abstract][Full Text] [Related]
20. Prognostic value of ploidy and proliferation markers in renal cell carcinoma. Tannapfel A; Hahn HA; Katalinic A; Fietkau RJ; Kühn R; Wittekind CW Cancer; 1996 Jan; 77(1):164-71. PubMed ID: 8630925 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]